SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950005-96-000930
Filing Date
1996-11-15
Accepted
1996-11-15 00:00:00
Documents
2
Period of Report
1996-06-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A 10-Q/A 3465
2 TANABE AGREEMENT EX-10.31 125801
  Complete submission text file 0000950005-96-000930.txt   130697
Mailing Address
Business Address 3832 BAY CENTER PLACE HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-22570 | Film No.: 96667627
SIC: 2833 Medicinal Chemicals & Botanical Products